Vitamin c toxicity and safety
Pro Research Analysisby 
Searched over 200M research papers
Vitamin C Safety: General Overview and Toxicity Risks
Vitamin C is widely recognized as a safe nutrient, especially at recommended dietary intakes. However, concerns arise with high-dose supplementation, particularly intravenous (IV) administration. Most studies show that vitamin C, even at high doses, is generally safe for the majority of people, but certain risks and side effects have been documented, especially in specific populations or with very high doses Doseděl2021Khoshnam-Rad2019.
High-Dose Vitamin C: Adverse Events and Renal Safety
Multiple systematic reviews and meta-analyses in critically ill patients and those with COVID-19 have found that high-dose IV vitamin C does not significantly increase the risk of adverse kidney events, acute kidney injury (AKI), or mortality compared to placebo or standard care Yanase2020Shrestha2021Shrestha2021+1 MORE. In fact, some studies report a slight reduction in ICU length of stay with vitamin C treatment Shrestha2021Shrestha2021. However, rare cases of oxalate nephropathy (a type of kidney damage), hypernatremia, and kidney stones have been reported, especially in susceptible individuals Yanase2020Doseděl2021Khoshnam-Rad2019.
Hemolysis and G6PD Deficiency: A Key Safety Concern
A well-documented risk of high-dose vitamin C is hemolysis (destruction of red blood cells) in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency. Several case reports and reviews highlight that hemolysis can occur rapidly after starting vitamin C, sometimes leading to severe complications such as acute kidney injury or even death. This risk is particularly relevant for those with known or suspected G6PD deficiency, and caution is advised in these patients Yanase2020Juneja2022Khoshnam-Rad2019.
Other Potential Side Effects and Special Populations
While most people tolerate high-dose vitamin C well, certain groups require extra caution. Patients with renal dysfunction, a history of kidney stones, oxaluria, or hemochromatosis may be at higher risk for adverse effects and should be monitored closely if high doses are considered Yanase2020Doseděl2021Khoshnam-Rad2019. Minor side effects, such as transient discomfort during infusion, have been reported but are generally not serious .
Cellular Toxicity and Pro-Oxidant Effects
At very high concentrations, vitamin C can act as a pro-oxidant rather than an antioxidant, potentially causing cellular toxicity. This effect is more pronounced in certain cell types, such as undifferentiated stem cells and cancer stem cells, where high-dose vitamin C can induce DNA damage and cell death. While this property is being explored for potential cancer therapies, it also underscores the need for careful dosing and monitoring Doseděl2021Kim2018.
Conclusion
Vitamin C is generally safe at recommended doses and even at higher doses for most people. However, high-dose vitamin C—especially IV administration—can cause serious side effects in susceptible individuals, including those with G6PD deficiency, renal dysfunction, or a history of kidney stones. Most clinical studies in critically ill and hospitalized patients show no significant increase in adverse events, but rare complications do occur. Careful patient selection, monitoring, and awareness of risk factors are essential to ensure the safe use of high-dose vitamin C Yanase2020Doseděl2021Juneja2022+5 MORE.
Sources and full results
Most relevant research papers on this topic
Vitamin C—Sources, Physiological Role, Kinetics, Deficiency, Use, Toxicity, and Determination
Vitamin C plays a diverse role in various processes, but high doses can cause side effects, such as oxalate renal stones, and its safety is relatively unknown in the general population.
Vitamin C-induced Hemolysis: Meta-summary and Review of Literature
Vitamin C is generally safe, but high doses and G6PD deficiency can lead to potential complications like severe hemolysis and acute kidney injury.
DOI
Safety of High-Dose Vitamin C in Critically Ill Patients: A Systematic Review and Meta-analysis
High-dose intravenous vitamin C (HDIVC) is renally safe and does not increase adverse kidney events or mortality, and may slightly reduce ICU length of stay in critically ill patients.
DOI